Mr. Chair, on the question of the motion on bulk exports, there is no argument anywhere in the House. There is a principle of many members of the House, especially the party to which the member used to belong, and that is we should consult with our stakeholders. I agree with that, but sometimes it is still in the process. We are going through that period now.
Also the question of having the proper legislative and regulatory framework to do that in light of our international commitments, our international contracts and engagements and treaties and trade arrangements makes it necessary to bring legislation forward. We have to do it. We are going through that process now to ensure we protect our drug supply.
The earlier comment that the price of drugs is not at risk by Internet pharmacies and bulk exports is not true. Our price control mechanism is at the factory gate and not necessarily at the pharmacy level or consumer level. If we restrict the supply and the demand remains the same, there is a risk of a price increase. It is important to maintain a good and proper supply to meet Canada's needs.